ExPASy logo ExPASy Home page Site Map Search ExPASy Contact us Swiss-Prot
Notice: This page will be replaced with www.uniprot.org. Please send us your feedback!
Search for

UniProtKB/Swiss-Prot entry P37023


[Entry info] [Name and origin] [References] [Comments] [Cross-references] [Keywords] [Features] [Sequence] [Tools]

Note: most headings are clickable, even if they don't appear as links. They link to the user manual or other documents.
Entry information
Entry name ACVL1_HUMAN
Primary accession number P37023
Secondary accession number A6NGA8
Integrated into Swiss-Prot on June 1, 1994
Sequence was last modified on December 15, 1998 (Sequence version 2)
Annotations were last modified on    June 10, 2008 (Entry version 92)
Name and origin of the protein
Protein name Serine/threonine-protein kinase receptor R3 [Precursor]
Synonyms EC 2.7.11.30
SKR3
Activin receptor-like kinase 1
ALK-1
TGF-B superfamily receptor type I
TSR-I
Gene name
Name: ACVRL1
Synonyms: ACVRLK1, ALK1
From
Homo sapiens (Human) [TaxID: 9606] 
Taxonomy Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo.
Protein existence 1: Evidence at protein level;
References
[1]
NUCLEOTIDE SEQUENCE [MRNA].
TISSUE=Placenta;
PubMed=8397373 [NCBI, ExPASy, EBI, Israel, Japan]
ten Dijke P., Ichijo H., Franzen P., Schulz P., Saras J., Toyoshima H., Heldin C.-H., Miyazono K.;
"Activin receptor-like kinases: a novel subclass of cell-surface receptors with predicted serine/threonine kinase activity.";
Oncogene 8:2879-2887(1993).
[2]
NUCLEOTIDE SEQUENCE [MRNA].
DOI=10.1016/0092-8674(93)90488-C; PubMed=8242742 [NCBI, ExPASy, EBI, Israel, Japan]
Attisano L., Carcamo J., Ventura F., Weis F.M., Massague J., Wrana J.L.;
"Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors.";
Cell 75:671-680(1993).
[3]
NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS HHT2 CYS-50; GLN-67; ILE-333; TRP-374 AND THR-424.
PubMed=9245985 [NCBI, ExPASy, EBI, Israel, Japan]
Berg J.N., Gallione C.J., Stenzel T.T., Johnson D.W., Allen W.P., Schwartz C.E., Jackson C.E., Porteous M.E.M., Marchuk D.A.;
"The activin receptor-like kinase 1 gene: genomic structure and mutations in hereditary hemorrhagic telangiectasia type 2.";
Am. J. Hum. Genet. 61:60-67(1997).
[4]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature04569; PubMed=16541075 [NCBI, ExPASy, EBI, Israel, Japan]
Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K., Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D., Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J., Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A., Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M., Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I., Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A., Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G., Gibbs R.A.;
"The finished DNA sequence of human chromosome 12.";
Nature 440:346-351(2006).
[5]
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C.;
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
[6]
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
TISSUE=Brain;
DOI=10.1101/gr.2596504; PubMed=15489334 [NCBI, ExPASy, EBI, Israel, Japan]
The MGC Project Team;
"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).";
Genome Res. 14:2121-2127(2004).
[7]
VARIANTS HHT2 SER-232 DEL; ARG-376 AND GLN-411.
DOI=10.1038/ng0696-189; PubMed=8640225 [NCBI, ExPASy, EBI, Israel, Japan]
Johnson D.W., Berg J.N., Baldwin M.A., Gallione C.J., Marondel I., Yoon S.-J., Stenzel T.T., Speer M., Pericak-Vance M.A., Diamond A., Guttmacher A.E., Jackson C.E., Attisano L., Kucherlapati R., Porteous M.E.M., Marchuk D.A.;
"Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2.";
Nat. Genet. 13:189-194(1996).
[8]
VARIANTS HHT2 TYR-51; TRP-77 AND ASP-96.
DOI=10.1002/(SICI)1098-1004(1998)12:2<137::AID-HUMU15>3.3.CO;2-D; PubMed=10694922 [NCBI, ExPASy, EBI, Israel, Japan]
Klaus D.J., Gallione C.J., Anthony K., Yeh E.Y., Yu J., Lux A., Johnson D.W., Marchuk D.A.;
"Novel missense and frameshift mutations in the activin receptor-like kinase-1 gene in hereditary hemorrhagic telangiectasia.";
Hum. Mutat. 12:137-137(1998).
[9]
VARIANTS HHT2 GLY-48-49-ALA DELINS EP; CYS-50; SER-232 DEL; ILE-333; TYR-344 AND ASP-407.
DOI=10.1093/hmg/9.8.1227; PubMed=10767348 [NCBI, ExPASy, EBI, Israel, Japan]
Abdalla S.A., Pece-Barbara N., Vera S., Tapia E., Paez E., Bernabeu C., Letarte M.;
"Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2.";
Hum. Mol. Genet. 9:1227-1237(2000).
[10]
VARIANTS HHT2 TRP-374 AND ASN-398.
DOI=10.1002/1096-8628(20010201)98:4<298::AID-AJMG1093>3.0.CO;2-K; PubMed=11170071 [NCBI, ExPASy, EBI, Israel, Japan]
Kjeldsen A.D., Brusgaard K., Poulsen L., Kruse T., Rasmussen K., Green A., Vase P.;
"Mutations in the ALK-1 gene and the phenotype of hereditary hemorrhagic telangiectasia in two large Danish families.";
Am. J. Med. Genet. 98:298-302(2001).
[11]
VARIANTS HHT2 ASP-254 DEL; TRP-411 AND TRP-484.
DOI=10.1056/NEJM200108023450503; PubMed=11484689 [NCBI, ExPASy, EBI, Israel, Japan]
Trembath R.C., Thomson J.R., Machado R.D., Morgan N.V., Atkinson C., Winship I., Simonneau G., Galie N., Loyd J.E., Humbert M., Nichols W.C., Berg J., Manes A., McGaughran J., Pauciulo M., Wheeler L., Morrell N.W.;
"Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.";
N. Engl. J. Med. 345:325-334(2001).
[12]
VARIANTS HHT2 ALA-179; ASP-211; TYR-344; TRP-374; GLN-374; SER-399; GLN-411 AND THR-487, AND CHARACTERIZATION OF VARIANTS HHT2 CYS-50; GLN-67; TRP-77; ALA-179; ASP-211; SER-232 DEL; ASP-254 DEL; ILE-333; TYR-344; GLN-374; LEU-378; GLN-411 AND THR-487.
DOI=10.1136/jmg.40.12.865; PubMed=14684682 [NCBI, ExPASy, EBI, Israel, Japan]
Harrison R.E., Flanagan J.A., Sankelo M., Abdalla S.A., Rowell J., Machado R.D., Elliott C.G., Robbins I.M., Olschewski H., McLaughlin V., Gruenig E., Kermeen F., Halme M., Raeisaenen-Sokolowski A., Laitinen T., Morrell N.W., Trembath R.C.;
"Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia.";
J. Med. Genet. 40:865-871(2003).
[13]
ERRATUM.
Harrison R.E., Flanagan J.A., Sankelo M., Abdalla S.A., Rowell J., Machado R.D., Elliott C.G., Robbins I.M., Olschewski H., McLaughlin V., Gruenig E., Kermeen F., Halme M., Raeisaenen-Sokolowski A., Laitinen T., Morrell N.W., Trembath R.C.;
J. Med. Genet. 41:576-576(2004).
[14]
VARIANTS HHT2 ARG-48; LYS-215; ARG-223; ARG-229; SER-233 DEL; PHE-285; PRO-306; TYR-314; PRO-337; PRO-347; GLN-374; VAL-376; LYS-379; GLY-397; TRP-411; PRO-411; GLN-411; LEU-425; LEU-479; VAL-482 AND TRP-484.
DOI=10.1002/humu.20017; PubMed=15024723 [NCBI, ExPASy, EBI, Israel, Japan]
French Rendu-Osler network;
Lesca G., Plauchu H., Coulet F., Lefebvre S., Plessis G., Odent S., Riviere S., Leheup B., Goizet C., Carette M.-F., Cordier J.-F., Pinson S., Soubrier F., Calender A., Giraud S.;
"Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France.";
Hum. Mutat. 23:289-299(2004).
[15]
VARIANTS HHT2 TRP-67; TRP-374; LYS-379; ASP-407; TRP-411; VAL-425 AND PHE-425 DEL.
DOI=10.1002/humu.9311; PubMed=15712270 [NCBI, ExPASy, EBI, Israel, Japan]
Kuehl H.K.A., Caselitz M., Hasenkamp S., Wagner S., El-Harith E.-H.A., Manns M.P., Stuhrmann M.;
"Hepatic manifestation is associated with ALK1 in hereditary hemorrhagic telangiectasia: identification of five novel ALK1 and one novel ENG mutations.";
Hum. Mutat. 25:320-320(2005).
Comments
Copyright
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms. Distributed under the Creative Commons Attribution-NoDerivs License.
Cross-references
Sequence databases
EMBL
Z22533; CAA80255.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
L17075; AAA16160.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U77713; AAB61900.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U77707; AAB61900.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U77708; AAB61900.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U77709; AAB61900.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U77710; AAB61900.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U77711; AAB61900.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
U77712; AAB61900.1; JOINED; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
AC025259; -; NOT_ANNOTATED_CDS; Genomic_DNA.[EMBL / GenBank / DDBJ]
CH471111; EAW58213.1; -; Genomic_DNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
BC042637; AAH42637.1; -; mRNA.[EMBL / GenBank / DDBJ] [CoDingSequence]
PIR A49431; A49431.
RefSeq NP_000011.2; -.
NP_001070869.1; -.
UniGene Hs.591026
3D structure databases
HSSP P36897; 1IAS. [HSSP ENTRY / PDB]
ModBase P37023.
Protein-protein interaction databases
DIP DIP:423N; -.
DIP:5938N; -.
PTM databases
PhosphoSite P37023; -.
Organism-specific databases
HGNC HGNC:175; ACVRL1.
GeneLynx ACVRL1; Homo sapiens.
GenAtlas ACVRL1.
HPA HPA007041; -.
MIM 600376; phenotype. [NCBI / EBI]
601284; gene. [NCBI / EBI]
Orphanet 774; Rendu-Osler-Weber disease.
PharmGKB PA24496; -.
GeneCards P37023.
Gene expression databases
ArrayExpress P37023; -.
CleanEx HS_ACVRL1; -.
GermOnline ENSG00000139567; Homo sapiens.
Ontologies
GO
GO:0009986; Cellular component: cell surface (inferred from direct assay from MGI).
GO:0005887; Cellular component: integral to plasma membrane (inferred from direct assay from UniProtKB).
GO:0048185; Molecular function: activin binding (inferred from direct assay from UniProtKB).
GO:0016361; Molecular function: activin receptor activity, type I (inferred from direct assay from MGI).
GO:0005524; Molecular function: ATP binding (inferred from direct assay from HGNC).
GO:0046332; Molecular function: SMAD binding (inferred from direct assay from HGNC).
GO:0050431; Molecular function: transforming growth factor beta binding (inferred from physical interaction from UniProtKB).
GO:0001525; Biological process: angiogenesis (inferred from mutant phenotype from HGNC).
GO:0030336; Biological process: negative regulation of cell migration (inferred from mutant phenotype from HGNC).
GO:0008285; Biological process: negative regulation of cell proliferation (inferred from mutant phenotype from HGNC).
GO:0051895; Biological process: negative regulation of focal adhesion formation (inferred from mutant phenotype from HGNC).
GO:0045941; Biological process: positive regulation of transcription (inferred from direct assay from HGNC).
GO:0006468; Biological process: protein amino acid phosphorylation (inferred from direct assay from HGNC).
GO:0008217; Biological process: regulation of blood pressure (inferred from mutant phenotype from HGNC).
GO:0007179; Biological process: transforming growth factor beta receptor signaling pathway (traceable author statement from UniProtKB).
GO:0035313; Biological process: wound healing, spreading of epidermal cells (inferred from mutant phenotype from HGNC).
QuickGo view.
Family and domain databases
InterPro IPR000333; Activin_II_recpt.
IPR000472; Activin_rcpt.
IPR000719; Prot_kinase_core.
IPR017441; Protein_kinase_ATP_bd_CS.
IPR008271; Ser_thr_pkin_AS.
IPR003605; TGF_beta_rcpt_GS.
Graphical view of domain structure.
Pfam PF01064; Activin_recp; 1.
PF08515; TGF_beta_GS; 1.
Pfam graphical view of domain structure.
PRINTS PR00653; ACTIVIN2R.
ProDom PD000001; Prot_kinase; 1.
[Domain structure / List of seq. sharing at least 1 domain]
SMART SM00467; GS; 1.
SMART graphical view of domain structure.
PROSITE PS51256; GS; 1.
PS00107; PROTEIN_KINASE_ATP; 1.
PS50011; PROTEIN_KINASE_DOM; 1.
PS00108; PROTEIN_KINASE_ST; 1.
PROSITE graphical view of domain structure (profiles).
BLOCKS P37023.
Genome annotation databases
Ensembl ENSG00000139567; Homo sapiens. [Contig view]
GeneID 94; -.
KEGG hsa:94; -.
Phylogenomic databases
HOGENOM P37023; -.
HOVERGEN P37023; -.
Other
DrugBank DB00171; Adenosine triphosphate.
SOURCE ACVRL1; Homo sapiens.
ProtoNet P37023.
UniRef View cluster of proteins with at least 50% / 90% / 100% identity.
Keywords
ATP-binding; Disease mutation; Glycoprotein; Kinase; Magnesium; Manganese; Membrane; Metal-binding; Nucleotide-binding; Polymorphism; Receptor; Serine/threonine-protein kinase; Signal; Transferase; Transmembrane.
Features
SEVIEWER logo Feature table viewer FT aligner logo Feature aligner
KeyFrom   To Length Description FTId
SIGNAL   1    21  21     Potential. 
CHAIN   22   503  482     Serine/threonine-protein kinase receptor R3. PRO_0000024420
TOPO_DOM   22   118  97     Extracellular (Potential). 
TRANSMEM   119   141  23     Potential. 
TOPO_DOM   142   503  362     Cytoplasmic (Potential). 
DOMAIN   172   201  30     GS. 
DOMAIN   202   492  291     Protein kinase. 
NP_BIND   208   216  9     ATP (By similarity). 
ACT_SITE   330   330        Proton acceptor (By similarity). 
BINDING   229   229        ATP (By similarity). 
CARBOHYD   98    98        N-linked (GlcNAc...) (Potential). 
VARIANT   48    49  2     GA -> EP (in HHT2). VAR_026784
VARIANT   48    48  1     G -> R (in HHT2). VAR_026785 
VARIANT   50    50  1     W -> C (in HHT2; retained in the cell cytoplasm in the endoplasmic reticulum). VAR_006204 
VARIANT   51    51  1     C -> Y (in HHT2). VAR_006205 
VARIANT   67    67  1     R -> Q (in HHT2; retained in the cell cytoplasm in the endoplasmic reticulum). VAR_006206 
VARIANT   67    67  1     R -> W (in HHT2). VAR_026786 
VARIANT   77    77  1     C -> W (in HHT2; retained in the cell cytoplasm in the endoplasmic reticulum). VAR_006207 
VARIANT   96    96  1     N -> D (in HHT2). VAR_006208 
VARIANT   179   179  1     D -> A (in HHT2; mutant protein is capable of targeting the cell surface appropriately). VAR_026787 
VARIANT   211   211  1     G -> D (in HHT2; retained in the cell cytoplasm in the endoplasmic reticulum). VAR_026788 
VARIANT   215   215  1     E -> K (in HHT2). VAR_026789 
VARIANT   223   223  1     G -> R (in HHT2). VAR_026790 
VARIANT   229   229  1     K -> R (in HHT2). VAR_026791 
VARIANT   232   232  1     Missing (in HHT2; mutant protein is capable of targeting the cell surface appropriately). VAR_006209
VARIANT   233   233  1     Missing (in HHT2). VAR_026792
VARIANT   245   245  1     I -> N (in dbSNP:rs1804508 [NCBI]). VAR_011717 
VARIANT   254   254  1     Missing (in HHT2; retained in the cell cytoplasm in the endoplasmic reticulum). VAR_026793
VARIANT   285   285  1     L -> F (in HHT2). VAR_026794 
VARIANT   306   306  1     A -> P (in HHT2). VAR_026795 
VARIANT   314   314  1     H -> Y (in HHT2). VAR_026796 
VARIANT   333   333  1     S -> I (in HHT2; retained in the cell cytoplasm in the endoplasmic reticulum). VAR_006210 
VARIANT   337   337  1     L -> P (in HHT2). VAR_026797 
VARIANT   344   344  1     C -> Y (in HHT2; retained in the cell cytoplasm in the endoplasmic reticulum). VAR_026798 
VARIANT   347   347  1     A -> P (in HHT2). VAR_026799 
VARIANT   374   374  1     R -> Q (in HHT2; retained in the cell cytoplasm in the endoplasmic reticulum). VAR_026800 
VARIANT   374   374  1     R -> W (in HHT2). VAR_006211 
VARIANT   376   376  1     M -> R (in HHT2). VAR_006212 
VARIANT   376   376  1     M -> V (in HHT2). VAR_026801 
VARIANT   378   378  1     P -> L (in HHT2; retained in the cell cytoplasm in the endoplasmic reticulum). VAR_026802 
VARIANT   379   379  1     E -> K (in HHT2). VAR_026803 
VARIANT   397   397  1     D -> G (in HHT2). VAR_026804 
VARIANT   398   398  1     I -> N (in HHT2). VAR_026805 
VARIANT   399   399  1     W -> S (in HHT2). VAR_026806 
VARIANT   407   407  1     E -> D (in HHT2). VAR_026807 
VARIANT   411   411  1     R -> P (in HHT2). VAR_026808 
VARIANT   411   411  1     R -> Q (in HHT2; retained in the cell cytoplasm in the endoplasmic reticulum). VAR_006213 
VARIANT   411   411  1     R -> W (in HHT2). VAR_026809 
VARIANT   424   424  1     P -> T (in HHT2). VAR_006214 
VARIANT   425   425  1     F -> L (in HHT2). VAR_026810 
VARIANT   425   425  1     F -> V (in HHT2). VAR_026811 
VARIANT   425   425  1     Missing (in HHT2). VAR_026812